User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients.

Primary tabs

Gross, Stefanie Erdmann, Michael Haendle, Ina Voland, Steve Berger, Thomas Coulie, Pierre G. [UCL] Schuler-Thurner, Beatrice

Reports on long-term (≥10 years) effects of cancer vaccines are missing. Therefore, in 2002, we initiated a phase I/II trial in cutaneous melanoma patients to further explore the immunogenicity of our DC vaccine and to establish its long-term toxicity and clinical benefit after a planned 10-year followup.

Document type Article de périodique (Journal article) – Article de recherche
Publication date 2017
Language Anglais
Journal information "JCI insight" - Vol. 2, no.8 (2017)
Peer reviewed yes
e-issn 2379-3708
Publication status Publié
Affiliation UCL - SSS/DDUV - Institut de Duve
Links
Bibliographic reference Gross, Stefanie ; Erdmann, Michael ; Haendle, Ina ; Voland, Steve ; Berger, Thomas ; et. al. Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients.. In: JCI insight, Vol. 2, no.8 (2017)
Permanent URL http://hdl.handle.net/2078.1/186082